• SPX
  • $5,969.34
  • 0.35 %
  • $20.63
  • DJI
  • $44,296.51
  • 0.97 %
  • $426.16
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $19,003.65
  • 0.16 %
  • $31.23
Science 37 Holdings, Inc. (SNCE) Stock Price, News & Analysis

Science 37 Holdings, Inc. (SNCE) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$5.73
Day's range
$5.75
50-day range
$4.5
Day's range
$6.19
  • Country: US
  • ISIN: US8086442071
52 wk range
$3.73
Day's range
$12.96
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -3.18
  • Piotroski Score 4.00
  • Grade Outperform
  • Symbol (SNCE)
  • Company Science 37 Holdings, Inc.
  • Price $5.75
  • Changes Percentage (0.35%)
  • Change $0.02
  • Day Low $5.73
  • Day High $5.75
  • Year High $12.96

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 05/12/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$21.40
  • Trailing P/E Ratio -0.26869158878505
  • Forward P/E Ratio -0.26869158878505
  • P/E Growth -0.26869158878505
  • Net Income $-50,988,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Science 37 Holdings, Inc. Frequently Asked Questions

  • What is the Science 37 Holdings, Inc. stock price today?

    Today's price of Science 37 Holdings, Inc. is $5.75 — it has increased by +0.35% in the past 24 hours. Watch Science 37 Holdings, Inc. stock price performance more closely on the chart.

  • Does Science 37 Holdings, Inc. release reports?

    Yes, you can track Science 37 Holdings, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Science 37 Holdings, Inc. stock forecast?

    Watch the Science 37 Holdings, Inc. chart and read a more detailed Science 37 Holdings, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Science 37 Holdings, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Science 37 Holdings, Inc. stock ticker.

  • How to buy Science 37 Holdings, Inc. stocks?

    Like other stocks, SNCE shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Science 37 Holdings, Inc.'s EBITDA?

    Science 37 Holdings, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Science 37 Holdings, Inc.’s financial statements.

  • What is the Science 37 Holdings, Inc.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is -0.7268735655, which equates to approximately -72.69%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Science 37 Holdings, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Science 37 Holdings, Inc.'s financials relevant news, and technical analysis. Science 37 Holdings, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Science 37 Holdings, Inc. stock currently indicates a “sell” signal. For more insights, review Science 37 Holdings, Inc.’s technical analysis.

  • A revenue figure for Science 37 Holdings, Inc. for its last quarter?

    Science 37 Holdings, Inc. published it's last quarterly revenues at $14.89 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.